Fife-based Epipole lands £1.5 million funding round

Craig Robertson, Epipole chief executive officer

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

INVERKEITHING-based Epipole, the video retinal imaging specialist, has secured £1.5 million in new funding to prepare for introduction into the United States ophthalmic imaging market.

The company has also announced the appointment of Ian Stevens as chairman.

The financing was led by new investor Greenwood Way Capital with the Scottish Investment Bank, the investment arm of Scottish Enterprise, also participating.

Epipole’s patented technology enables clinicians to scan the retina using real-time video and then extract high quality images for further examination.

Retinal cameras are typically large and costly desktop systems, but Epipole believes it can revolutionise the sector with its portable design and cost-effective pricing.

Dr Craig Robertson, Epipole founder and chief executive officer, said:  “We’ve worked with ophthalmologists to test and refine features and capabilities, and will use this funding to implement the key changes needed.

“We will have a particular focus on the US primary care optometry and ophthalmology markets, and plan to have product available by early 2021.”

Mr Stevens, who has previously held the CEO position at Scottish businesses Touch Bionics, Mpathy Medical and BioFilm, said:  “I am delighted to join the company and look forward to working with Craig and his team as we seek to transform ophthalmic imaging with our new technology.”

Facebook
Twitter
LinkedIn

Related News

Our brands